NCT07741786

Brief Summary

Sarcopenia is an age-related skeletal muscle disorder characterized by reduced muscle strength, muscle mass, and physical performance. It may lead to impaired balance, reduced mobility, falls, loss of independence, and reduced quality of life. Exercise is a central component of sarcopenia management; however, the additional effects of proprioceptive neuromuscular facilitation exercises in older adults with sarcopenia remain unclear. This study compared proprioceptive neuromuscular facilitation-based exercise with conventional exercise in adults aged 65 years or older with sarcopenia. A total of 34 participants were assigned to either a proprioceptive neuromuscular facilitation group or a conventional exercise group. Both groups participated in supervised exercise sessions three times per week for 10 weeks, with each session lasting approximately 45 minutes. The conventional exercise program included lower-extremity strengthening, balance, functional mobility, sit-to-stand, gait, and stretching exercises. The proprioceptive neuromuscular facilitation group received the conventional exercise program together with proprioceptive neuromuscular facilitation techniques. Participants were evaluated at baseline, during the first month, and during the third month after initiation of the exercise program. Outcomes included balance, functional mobility, walking capacity, lower-extremity functional performance, stair performance, fear of falling, and depressive symptoms. Assessments included the Berg Balance Scale, Timed Up and Go Test, 6-Minute Walk Test, Five Times Sit-to-Stand Test, stair ascent and descent test, Tinetti Falls Efficacy Scale, and Geriatric Depression Scale.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 12, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 15, 2022

Completed
17 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2022

Completed
4 years until next milestone

First Submitted

Initial submission to the registry

July 28, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 3, 2026

Completed
Last Updated

August 3, 2026

Status Verified

July 1, 2026

Enrollment Period

5 months

First QC Date

July 28, 2026

Last Update Submit

July 28, 2026

Conditions

Keywords

SarcopeniaPNF exercisesBalanceFear of fallingResistance exercise

Outcome Measures

Primary Outcomes (1)

  • Change in Berg Balance Scale score

    Balance function was assessed using the Berg Balance Scale. Scores were measured at baseline, at the first-month assessment, and at the third-month assessment after initiation of the exercise program. Changes over time and differences between the groups were analyzed.

    Time Frame: Baseline, 1 month, and 3 months after initiation of the intervention

Secondary Outcomes (6)

  • Change in Tinetti Falls Efficacy Scale score

    Baseline, 1 month, and 3 months after initiation of the intervention

  • Change in Timed Up and Go Test performance

    Time Frame: Baseline, 1 month, and 3 months after initiation of the intervention

  • Change in 6-Minute Walk Test distance

    Time Frame: Baseline, 1 month, and 3 months after initiation of the intervention

  • Change in Five Times Sit-to-Stand Test time

    Time Frame: Baseline, 1 month, and 3 months after initiation of the intervention

  • Change in stair ascent and descent test time

    Time Frame: Baseline, 1 month, and 3 months after initiation of the intervention

  • +1 more secondary outcomes

Study Arms (2)

ARM 1 / Conventional Exercise Group

ACTIVE COMPARATOR

Participants in this group received a supervised conventional exercise program including lower-extremity strengthening, balance training, functional mobility exercises, sit-to-stand practice, gait exercises, and stretching. The exercise program was performed three days per week for 10 consecutive weeks, with each session lasting approximately 45 minutes. Exercise intensity and progression were individually adjusted according to each participant's functional capacity and clinical tolerance.

Behavioral: Conventional Exercise Program

ARM 2/Conventional Exercise Plus PNF Group

EXPERIMENTAL

Participants in this group received the same supervised conventional exercise program together with proprioceptive neuromuscular facilitation exercises. The PNF intervention included diagonal movement patterns, proprioceptive stimulation, coordinated neuromuscular activation, manual resistance, and task-oriented functional movement patterns. The combined exercise program was performed three days per week for 10 consecutive weeks, with each session lasting approximately 45 minutes. Exercise intensity and progression were individually adjusted according to each participant's functional capacity and clinical tolerance.

Behavioral: Conventional Exercise ProgramBehavioral: Proprioceptive Neuromuscular Facilitation Exercises

Interventions

Participants received a supervised conventional exercise program including lower-extremity strengthening, balance training, functional mobility exercises, sit-to-stand practice, gait exercises, and stretching. The program was performed three days per week for 10 consecutive weeks, with each session lasting approximately 45 minutes. Exercise intensity and progression were individualized according to functional capacity and clinical tolerance.

ARM 1 / Conventional Exercise GroupARM 2/Conventional Exercise Plus PNF Group

Participants received proprioceptive neuromuscular facilitation exercises in addition to the conventional exercise program. The PNF intervention included diagonal movement patterns, proprioceptive stimulation, coordinated neuromuscular activation, manual resistance, and task-oriented functional movement patterns designed to improve postural control, balance, gait, and lower-extremity functional performance. The combined program was performed three days per week for 10 consecutive weeks, with each session lasting approximately 45 minutes.

Also known as: PNF Exercises
ARM 2/Conventional Exercise Plus PNF Group

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Adults aged 65 years or older.
  • Diagnosis of sarcopenia according to the European Working Group on Sarcopenia in Older People criteria.
  • Ability to participate safely in the prescribed exercise program.
  • Completion of the baseline clinical assessment.
  • Provision of written informed consent to participate in the study.

You may not qualify if:

  • Parkinson's disease.
  • Previous stroke.
  • Multiple sclerosis.
  • Vestibular disorders or vertigo.
  • Other major neurological diseases that could affect balance, gait, mobility, or physical performance.
  • Severe musculoskeletal disorders that could independently affect balance, gait, mobility, or participation in exercise.
  • Uncontrolled cardiovascular disease.
  • Any medical condition that could preclude safe participation in the exercise program.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Facility Name: Uşak Training and Research Hospital

Uşak, Uşak, 64100, Turkey (Türkiye)

Location

Usak Training and Research Hospital, Physical Medicine and Rehabilitation Clinic

Uşak, Turkey (Türkiye)

Location

Related Publications (1)

  • • Pereira MP, Gonc¸alves M Proprioceptive Neuromuscular Facilitation Improves Balance and Knee Extensors Strength of Older Fallers. International Scholarly Research Network ISRN Rehabilitation. Volume 2012, Article ID 402612, 7 pages

    BACKGROUND

MeSH Terms

Conditions

Sarcopenia

Interventions

Muscle Stretching Exercises

Condition Hierarchy (Ancestors)

Muscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants were randomly allocated in a 1:1 ratio to one of two parallel groups using a computer-generated randomization sequence. The conventional exercise group received a program including lower-extremity strengthening, balance training, functional mobility exercises, sit-to-stand practice, gait exercises, and stretching. The PNF group received the same conventional exercise program together with proprioceptive neuromuscular facilitation techniques. Both groups participated in supervised exercise sessions three times per week for 10 consecutive weeks, with each session lasting approximately 45 minutes.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

July 28, 2026

First Posted

August 3, 2026

Study Start

February 12, 2022

Primary Completion

July 15, 2022

Study Completion

August 1, 2022

Last Updated

August 3, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared because the ethics approval and informed consent documents did not include permission for external sharing of individual-level data. Aggregate study results may be made available from the corresponding investigator upon reasonable request, subject to institutional and ethical regulations.

Locations